Citations

Clear

313 citation(s) found for "Alvarez, P".

Prognostic and predictive blood-based biomarkers (BMs) in patients (pts) with advanced epithelial ovarian cancer (EOC) treated with carboplatin–paclitaxel (CP) ± bevacizumab (BEV): Results from GOG-0218.
Tritchler, David , Starr, Mark D. , Brady, John C. , Hurwitz, Herbert I. , Mannel, Robert S., Tewari, Krishnansu S. , Gray, Heidi J. , Boente, Matthew, Deng, Wei , Burger, Robert A. , Birrer, Michael J. , Secord, Angeles Alvarez , Liu, Yingmiao , Lankes, Heather A. , O’Malley, David M. , Bakkum‐Gamez, Jamie N. , Fujiwara, Keiichi , Deng, Wei, Nixon, Andrew B.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 5521-5521

10.1200/jco.2016.34.15_suppl.5521 Get It

Detection of endoglin-expressing CTCs in patients enrolled in an adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS).
Ravi, Vinod , Chawla, Sant P. , Attia, Steven , Riedel, Richard F. , Thornton, Katherine A., Mallick, Atrayee Basu , Davis, Darren W. , Cervantes, Mario, Liu, Wen , Zhu, Keyi, Alvarez, Delia, Theuer, Charles P. , Tap, William D. , Jones, Robin L. , Maki, Robert G. , Maki, Robert G , Riedel, Richard F , Jones, Robin L , Brohl, Andrew S. , Liebner, David A. , Zhu, Keyi , Robinson, Steven I. , Penel, Nicolas , Stacchiotti, Silvia

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e23570-e23570

10.1200/jco.2018.36.15_suppl.e23570 Get It

QUADRA: A phase 2, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) who have received ≥3 prior chemotherapy regimens.
Miller, David S. , Cloven, Noelle, Hendrickson, Andrea E. Wahner , DiSilvestro, Paul , Cristea, Mihaela , Berek, Jonathan S. , Chan, John K. , Clark, Romnee, Matulonis, Ursula A. , Monk, Bradley J. , Miller, David S , Moore, Kathleen N. , Secord, Angeles Alvarez , Geller, Melissa Ann , Fleming, Gini F. , Azodi, Masoud , Oza, Amit M. , Li, Yong

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5514-5514

10.1200/jco.2018.36.15_suppl.5514 Get It

TAPPAS: An adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma.
Ravi, Vinod , Chawla, Sant P. , Attia, Steven , Riedel, Richard F. , Thornton, Katherine A., Mallick, Atrayee Basu , Liu, Lingyun , Alvarez, Delia, Theuer, Charles P. , Tap, William D. , Jones, Robin L. , Maki, Robert G. , Maki, Robert G , Riedel, Richard F , Jones, Robin L , Brohl, Andrew S. , Liebner, David A. , Mehta, Cyrus R. , Robinson, Steven I. , Penel, Nicolas , Stacchiotti, Silvia

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS11590-TPS11590

10.1200/jco.2018.36.15_suppl.tps11590 Get It

Assessment of activating estrogen receptor 1 (ESR1) mutations in gynecologic malignancies.
Gay, Laurie M. , Steiner, M., Andreano, Kaitlyn J., Davidson, Brittany A. , Colón‐Otero, Gerardo , Zajchowski, Deborah A., McDonnell, Donald P. , Elvin, Julia A. , Gaillard, Stéphanie , Havrilesky, Laura Jean , Secord, Angeles Alvarez , Valea, Fidel A. , Chang, Ching‐yi , Berchuck, Andrew , Elvin, Julia A

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5590-5590

10.1200/jco.2018.36.15_suppl.5590 Get It

A method to reduce variability in scoring antibody-mediated rejection in renal allografts: implications for clinical trials - a retrospective study
Smith, Byron H. , Cornell, Lynn D. , Cortese, Cherise , Geiger, Xochiquetzal J., Alexander, Mariam P., Ryan, Margaret , Park, Walter D. , Morales-Álvarez, Martha Catalina , Kremers, Walter K. , Stegall, Mark D. , Smith, Byron , Geiger, Xochiquetzal, Park, Walter, Morales Alvarez, Martha Catalina, Stegall, Mark, Stegall, Mark D , Park, Walter , Cornell, Lynn , Kremers, Walter K , Smith, Maxwell L. , Schinstock, Carrie A.

Mayo Clinic

Transplant International | September 4, 2018 | Volume: 32 | Issue: 2 | Pages: 173-183

10.1111/tri.13340 | PMID 30179275 Get It

Systematic review and meta-analysis of the effect of SGLT-2 inhibitors on microvascular outcomes in patients with type 2 diabetes: a review protocol
Dorsey-Treviño, Edgar Gerardo , Contreras-Garza, Belinda Maricela , González‐González, José Gerardo , Álvarez‐Villalobos, Neri Alejandro , Salcido‐Montenegro, Alejandro , González-Colmenero, Alejandro Díaz , González‐Nava, Victoria , Rodriguez‐Tamez, Giselle , Rodríguez‐Gutiérrez, René , Alvarez-Villalobos, Neri, Díaz González-Colmenero, Alejandro, Farrell, Ann M, González-Nava, Victoria, Rodríguez-Tamez, Giselle, Rodríguez-Gutiérrez, René , González-González, José Gerardo , Álvarez-Villalobos, Neri A , Farrell, Ann , Montori, Víctor M.

Mayo Clinic

BMJ Open | June 30, 2018 | Volume: 8 | Issue: 6 | Pages: e020692

10.1136/bmjopen-2017-020692 | PMID 29961013 Get It

Introduction Sodium glucose cotransporter 2 (SGLT-2) inhibitors are a relatively new drug-class of glucose-lowering medications. Several trials and systematic reviews have demonstrated their beneficial effect on some macrovascular outcomes. Their effect on microvascular outcomes has been reported as positive in several trials, however, their effect remains uncertain. Therefore, we report the protocol of a systematic review and meta-analysis aimed at determining the effect of SGLT-2 inhibitors regarding patient-important and surrogate microvascular outcomes in patients with type 2 diabetes. Methods and analysis A comprehensive search will be conducted to find eligible articles from each database’s earliest inception to November 2017. These databases will include Ovid, MEDLINE, EMBASE, Web of Science, and Scopus. We will search for randomized controlled trials (RCTs) that compare any of the SGLT-2 inhibitors with any other active treatment or placebo assessing microvascular outcomes in either their primary or secondary outcomes. Reviewers working independently and in duplicate will review all abstracts, and full-text manuscripts for eligibility, and will systematically extract the data and will assess the risk of bias in the included studies. Random-effects models will also be used. Ethics and dissemination The results of the systematic review will be disseminated via publication in a peer-reviewed journal regardless of outcome and will be presented at relevant conferences. The data we will use do not include individual patient data, so ethical approval is not required PROSPERO registration number CRD42017076460.
The Efficacy and Adverse Events of Testosterone Replacement Therapy in Hypogonadal Men: A Systematic Review and Meta-Analysis of Randomized, Placebo-Controlled Trials
Ponce, Oscar J. , Spencer‐Bonilla, Gabriela , Álvarez‐Villalobos, Neri Alejandro , Serrano, Valentina, Ospina, Naykky Singh , Rodríguez‐Gutiérrez, René , Salcido‐Montenegro, Alejandro , Benkhadra, Raed, Brito, Juan P. , Ospina, Naykky Singh , Alvarez-Villalobos, Neri, Álvarez-Villalobos, Neri A , Prokop, Larry J. , Bhasin, Shalender , Singh Ospina, Naykky , Brito, Juan P , Ponce, Oscar Josue

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | March 17, 2018 | Volume: 103 | Issue: 5 | Pages: 1745-1754

10.1210/jc.2018-00404 | PMID 29562341 Get It

Unilateral Versus Bilateral Lung Transplantation
Tangaroonsanti, Anupong, Lee, Augustine S. , Vela, Marcelo F. , Erasmus, D , Keller, Cesar A., Alvarez, Francisco , DeVault, Kenneth R. , Houghton, Lesley A. , Erasmus, David, Keller, Cesar, Mallea, Jorge, Houghton, L A , Crowell, Michael D. , Mallea, Jorge M. , Almansa, Cristina

Mayo Clinic

Journal of Clinical Gastroenterology | March 4, 2018 | Volume: 53 | Issue: 4 | Pages: 284-289

10.1097/mcg.0000000000001015 | PMID 29505550 Get It

Goals: To assess the effect of unilateral versus bilateral lung transplantation (LTx) on esophageal motility and gastroesophageal reflux, and the association with the development of obstructive chronic lung allograft dysfunction (o-CLAD). Background: We have shown that esophagogastric junction outflow obstruction, incomplete bolus transit, and proximal reflux are all independent risk factors for the development of chronic allograft failure. However, it remains unclear whether these factors are influenced by the type of surgery and how this relates to allograft failure. Study: Patients post-LTx (n=48, 24 female; aged 20 to 73 y) completed high-resolution impedance manometry and 24-hour pH/impedance. Results: Patients who had undergone unilateral LTx were more likely to exhibit esophagogastric junction outflow obstruction (47% vs. 18%; P=0.046) and less likely to exhibit hypocontractility (0% vs. 21%; P=0.058) than those who had undergone bilateral LTx. Although the proportion of patients exhibiting gastroesophageal reflux was no different between groups (33% vs. 39%; P=0.505), those undergoing bilateral LTx were more likely to exhibit proximal reflux (8% vs. 37%; P=0.067). Univariate Cox proportion hazards regression analysis did not show a difference between unilateral versus bilateral LTx in the development of o-CLAD (hazard ratio=1.17; 95% confidence interval, 0.48-2.85; P=0.723). Conclusion: The type of LTx performed seems to lead to different risk factors for the development of o-CLAD. Physicians should be aware of these differences, as they may need to be taken into account when managing patient’s post-LTx.